“…It has been suggested that individuals displaying increased quantities of constitutive heterochromatin or considerable heteromorphism of the C-bands of chromosome 1 may be more prone to chromosomal instability in somatic cells, perhaps due to increased rates of chromosome breakage and/or of somatic crossing over, thus facilitating genetic changes during neoplastic transformation 198.5). Several workers have found positive correlations between heteromorphism of constitutive heterochromatin in chromosome 1 and the development of various kinds of neoplasia, such as ovarian cancer (ATKIN and PICKTHALL 1977), carcinoma and dysplasia of the uterine cervix (HENEEN et al 1980;GHOSH et al 1986), breast cancer (BERGER et al 1985), malignancies of the head and neck (PET- KOVIC 1983), various solid tumors (SUCIU 1986), carcinoma of the colon and rectum (SHABTAI et al 1985), bladder carcinoma (ATKIN and BAKER 1977), chronic myeloid leukemia (BERGER et al 1979;SHABTAI and HALBRECHT 1979;RAJASEKARIAH and GARSON 1981;ADHVARYU et al 1987), acute leukemia and preleukemia (SHABTAI and HALBRECHT 1979;VINUESA et al 1984, 198.5), and multiple (reviewed by BRITO-BABAPULLE 1981, myeloma (RANNI et al 1987). In contrast, some workers could not find any correlation between Cband heteromorphism in chromosome 1 and cancer susceptibility in their studies of ovarian and breast carcinomas (KIVI andMIKELSAAR 1980, 1987), testicular tumors (ROBSON et al 1981), soft tissue sarcomas (BERGER et al 1983), tumors of the nervous system (REY et al 198.5, 1987), adenomatosis of the colon and rectum (HEIM et al 198S), and acute nonlymphocytic leukemias (CONIAT et al 1982).…”